Bavarian Nordic Logo

Bavarian Nordic

ISIN: DK0015998017 | Ticker: BAVA | LEI: 2138006JCDVYIN6INP51
Sector: Health CareSub-Industry: Biotechnology
Country: Denmark

About Bavarian Nordic

Company Description

For us, it is all about improving and saving lives
Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccines company focused on the development, manufacturing and commercialization of our vaccines, and our vision is to become one of the largest pure play vaccine companies in the world.

We are a global leader in smallpox and monkeypox vaccines and our commercial product portfolio contains market-leading vaccines against rabies and tick-borne encephalitis as well as an Ebola vaccine, which is developed using our live virus vaccine platform technology, MVA-BN®. Our late-stage pipeline comprises a novel COVID-19 vaccine for boosting existing immunity and a vaccine against respiratory syncytial virus (RSV), for which no approved vaccines exist today.

Year founded

1994

Headcount

900

Headquarters

Philip Heymans Alle 3, 2900 Hellerup – Denmark

Financial statements

Download as Excel
Line item in (dkk) 01.01.2020 01.04.2020 01.07.2020 01.01.2021 02.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 02.01.2022 01.04.2022 01.07.2022 01.10.2022 01.01.2023 02.01.2023 01.04.2023 01.07.2023 01.10.2023
Assets N/A 9,005,271,000.00 9,242,710,000.00 8,759,064,000.00 N/A 9,748,434,000.00 10,008,378,000.00 10,117,524,000.00 12,089,269,000.00 N/A 11,991,549,000.00 12,028,556,000.00 12,295,000,000.00 12,391,246,000.00 N/A N/A 14,993,241,000.00 13,399,238,000.00
Noncurrent Assets N/A 6,374,683,000.00 6,354,989,000.00 6,378,017,000.00 N/A 6,405,533,000.00 6,426,395,000.00 6,523,564,000.00 7,335,630,000.00 N/A 7,552,124,000.00 7,670,807,000.00 7,749,236,000.00 7,906,666,000.00 N/A N/A 10,578,155,000.00 8,938,037,000.00
Property Plant And Equipment N/A 860,128,000.00 894,095,000.00 1,011,156,000.00 N/A 1,078,751,000.00 1,148,419,000.00 1,262,696,000.00 1,412,668,000.00 N/A 1,541,675,000.00 1,612,247,000.00 1,644,001,000.00 1,683,973,000.00 N/A N/A 2,322,704,000.00 2,295,728,000.00
Land And Buildings N/A 158,005,000.00 161,306,000.00 366,232,000.00 N/A 367,830,000.00 361,054,000.00 354,187,000.00 345,953,000.00 N/A 340,492,000.00 334,774,000.00 329,491,000.00 630,138,000.00 N/A 619,889,000.00 933,098,000.00 930,523,000.00
Machinery N/A 43,261,000.00 83,171,000.00 204,664,000.00 N/A 269,266,000.00 263,583,000.00 255,972,000.00 254,530,000.00 N/A 250,381,000.00 243,067,000.00 236,382,000.00 321,745,000.00 N/A 311,458,000.00 407,603,000.00 402,279,000.00
Construction In Progress N/A 633,261,000.00 620,966,000.00 213,309,000.00 N/A 215,374,000.00 301,398,000.00 421,696,000.00 578,707,000.00 N/A 722,638,000.00 810,638,000.00 846,457,000.00 196,130,000.00 N/A 225,964,000.00 242,948,000.00 235,243,000.00
Intangible Assets Other Than Goodwill N/A 5,424,399,000.00 5,373,285,000.00 5,290,752,000.00 N/A 5,234,554,000.00 5,189,871,000.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Computer Software N/A 20,693,000.00 18,797,000.00 17,631,000.00 N/A 16,623,000.00 28,791,000.00 26,594,000.00 22,985,000.00 N/A 23,208,000.00 19,754,000.00 16,352,000.00 14,768,000.00 N/A 13,207,000.00 18,141,000.00 15,134,000.00
Copyrights Patents And Other Industrial Property Rights Service And Operating Rights N/A N/A N/A N/A N/A 5,117,531,000.00 5,049,298,000.00 4,981,064,000.00 4,912,830,000.00 N/A 4,844,596,000.00 4,776,363,000.00 4,708,129,000.00 4,639,895,000.00 N/A 4,571,661,000.00 5,360,221,000.00 5,281,232,000.00
Intangible Assets Under Development N/A 13,240,000.00 32,255,000.00 57,543,000.00 N/A 70,587,000.00 81,969,000.00 105,314,000.00 134,371,000.00 N/A 168,185,000.00 204,145,000.00 242,805,000.00 274,490,000.00 N/A 312,458,000.00 356,162,000.00 363,035,000.00
Noncurrent Prepayments N/A N/A N/A N/A N/A N/A N/A 14,772,000.00 38,385,000.00 N/A 47,464,000.00 164,750,000.00 164,793,000.00 207,537,000.00 N/A 219,425,000.00 236,371,000.00 7,327,000.00
Other Noncurrent Receivables N/A 3,625,000.00 3,959,000.00 4,122,000.00 N/A 4,562,000.00 4,683,000.00 4,692,000.00 4,778,000.00 N/A 4,845,000.00 4,969,000.00 5,310,000.00 5,086,000.00 N/A 9,037,000.00 12,156,000.00 12,176,000.00
Deferred Tax Assets N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 1,723,000.00 1,747,000.00
Current Assets N/A 2,630,588,000.00 2,887,721,000.00 2,381,047,000.00 N/A 3,342,901,000.00 3,581,983,000.00 3,593,960,000.00 4,753,639,000.00 N/A 4,439,425,000.00 4,357,749,000.00 4,545,764,000.00 4,484,580,000.00 N/A N/A 4,415,086,000.00 4,461,201,000.00
Inventories N/A 186,764,000.00 154,596,000.00 521,082,000.00 N/A 552,831,000.00 667,443,000.00 553,278,000.00 480,043,000.00 N/A 603,570,000.00 518,409,000.00 591,214,000.00 919,072,000.00 N/A N/A 1,508,403,000.00 1,739,948,000.00
Trade And Other Current Receivables N/A 238,674,000.00 353,218,000.00 190,358,000.00 N/A 201,448,000.00 401,092,000.00 402,618,000.00 556,981,000.00 N/A 388,786,000.00 585,901,000.00 712,972,000.00 720,342,000.00 N/A N/A 1,521,784,000.00 1,215,007,000.00
Current Trade Receivables N/A 210,604,000.00 318,286,000.00 139,292,000.00 N/A 159,187,000.00 339,955,000.00 302,973,000.00 381,624,000.00 N/A 285,396,000.00 506,890,000.00 654,282,000.00 523,145,000.00 N/A 741,363,000.00 1,310,244,000.00 1,162,322,000.00
Current Prepayments N/A 9,140,000.00 9,916,000.00 13,732,000.00 N/A 18,845,000.00 33,300,000.00 56,430,000.00 108,840,000.00 N/A 67,228,000.00 49,635,000.00 32,513,000.00 153,934,000.00 N/A 165,238,000.00 177,632,000.00 32,423,000.00
Other Current Receivables N/A 18,183,000.00 24,001,000.00 37,334,000.00 N/A 23,416,000.00 27,837,000.00 43,215,000.00 66,517,000.00 N/A 36,162,000.00 29,376,000.00 26,177,000.00 43,263,000.00 N/A 42,290,000.00 33,824,000.00 20,178,000.00
Current Tax Assets Current N/A 747,000.00 1,015,000.00 0.00 N/A 0.00 0.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A 84,000.00 84,000.00
Cash and cash equivalents 297,545,000.00 1,464,523,000.00 376,921,000.00 285,487,000.00 285,487,000.00 245,835,000.00 185,901,000.00 341,822,000.00 591,820,000.00 591,820,000.00 401,366,000.00 290,801,000.00 718,646,000.00 575,407,000.00 575,407,000.00 1,271,717,000.00 831,802,000.00 1,032,182,000.00
Equity And Liabilities N/A 9,005,271,000.00 9,242,710,000.00 8,759,064,000.00 N/A 9,748,434,000.00 10,008,378,000.00 10,117,524,000.00 12,089,269,000.00 N/A 11,991,549,000.00 12,028,556,000.00 12,295,000,000.00 12,391,246,000.00 N/A N/A 14,993,241,000.00 13,399,238,000.00
Equity 1,865,455,000.00 5,110,553,000.00 5,251,149,000.00 4,894,353,000.00 N/A 5,920,743,000.00 5,788,550,000.00 5,770,699,000.00 7,374,667,000.00 N/A 7,125,298,000.00 6,879,095,000.00 6,957,830,000.00 7,149,987,000.00 N/A N/A 9,685,751,000.00 9,335,863,000.00
Issued Capital N/A 583,003,000.00 584,501,000.00 584,501,000.00 N/A 637,368,000.00 638,172,000.00 640,651,000.00 704,684,000.00 N/A 704,729,000.00 704,793,000.00 706,943,000.00 707,354,000.00 N/A N/A 779,286,000.00 779,286,000.00
Retained Earnings N/A 4,444,869,000.00 4,576,142,000.00 4,246,359,000.00 N/A 5,224,064,000.00 5,086,384,000.00 5,069,631,000.00 6,588,908,000.00 N/A 6,323,560,000.00 6,082,702,000.00 6,131,979,000.00 6,300,575,000.00 N/A N/A 8,766,964,000.00 8,426,317,000.00
Treasury Shares N/A 599,000.00 553,000.00 1,077,000.00 N/A 946,000.00 1,176,000.00 1,176,000.00 1,112,000.00 N/A 871,000.00 1,463,000.00 1,463,000.00 1,463,000.00 N/A N/A 1,537,000.00 1,537,000.00
Other Reserves N/A 83,280,000.00 91,059,000.00 64,570,000.00 N/A 60,257,000.00 65,170,000.00 61,593,000.00 82,187,000.00 N/A 97,880,000.00 93,063,000.00 120,371,000.00 143,521,000.00 N/A N/A 141,038,000.00 131,797,000.00
Liabilities N/A 3,894,718,000.00 3,991,561,000.00 3,864,711,000.00 N/A 3,827,691,000.00 4,219,828,000.00 4,346,825,000.00 4,714,602,000.00 N/A 4,866,251,000.00 5,149,461,000.00 5,337,170,000.00 5,241,259,000.00 N/A N/A 5,307,490,000.00 4,063,375,000.00
Noncurrent Liabilities N/A 3,184,714,000.00 3,256,008,000.00 2,912,401,000.00 N/A 2,378,114,000.00 2,391,883,000.00 2,034,090,000.00 2,806,044,000.00 N/A 2,834,985,000.00 2,953,327,000.00 3,023,692,000.00 2,953,919,000.00 N/A N/A 2,381,071,000.00 1,176,305,000.00
Noncurrent Provisions For Employee Benefits N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 55,617,000.00 56,375,000.00
Deferred Tax Liabilities N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 27,421,000.00 27,794,000.00
Current Liabilities N/A 710,004,000.00 735,553,000.00 952,310,000.00 N/A 1,449,577,000.00 1,827,945,000.00 2,312,735,000.00 1,908,558,000.00 N/A 2,031,266,000.00 2,196,134,000.00 2,313,478,000.00 2,287,340,000.00 N/A N/A 2,926,419,000.00 2,887,070,000.00
Trade And Other Current Payables To Trade Suppliers N/A 150,910,000.00 201,496,000.00 345,320,000.00 N/A 273,291,000.00 298,545,000.00 222,795,000.00 263,611,000.00 N/A 204,418,000.00 195,456,000.00 381,904,000.00 605,928,000.00 N/A 444,834,000.00 764,233,000.00 793,693,000.00
Current Advances N/A 28,117,000.00 26,472,000.00 74,347,000.00 N/A 72,691,000.00 51,435,000.00 50,755,000.00 16,904,000.00 N/A 120,415,000.00 118,225,000.00 19,327,000.00 0.00 N/A N/A 111,000.00 N/A
Current Tax Liabilities Current N/A 0.00 0.00 497,000.00 N/A 1,126,000.00 1,461,000.00 2,063,000.00 3,743,000.00 N/A 3,976,000.00 4,484,000.00 6,663,000.00 6,337,000.00 N/A N/A 7,469,000.00 7,611,000.00
Other Current Liabilities N/A 79,863,000.00 124,391,000.00 151,814,000.00 N/A 146,218,000.00 198,617,000.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Line item in (dkk) 01.01.2020/
01.04.2020
01.01.2020/
01.07.2020
01.01.2020/
01.01.2021
01.04.2020/
01.07.2020
01.01.2021/
01.04.2021
01.01.2021/
01.07.2021
01.01.2021/
01.10.2021
01.01.2021/
01.01.2022
01.04.2021/
01.07.2021
01.07.2021/
01.10.2021
01.01.2022/
01.04.2022
01.01.2022/
01.07.2022
01.01.2022/
01.10.2022
01.01.2022/
01.01.2023
01.04.2022/
01.07.2022
01.07.2022/
01.10.2022
01.01.2023/
01.04.2023
01.01.2023/
01.07.2023
01.01.2023/
01.10.2023
01.04.2023/
01.07.2023
01.07.2023/
01.10.2023
Revenue 365,405,000.00 1,064,980,000.00 1,852,383,000.00 699,575,000.00 535,253,000.00 905,252,000.00 1,353,908,000.00 1,897,875,000.00 369,999,000.00 448,656,000.00 320,056,000.00 856,755,000.00 1,860,320,000.00 3,150,793,000.00 536,699,000.00 1,003,565,000.00 N/A 3,238,680,000.00 4,615,080,000.00 1,986,627,000.00 1,376,400,000.00
Other Income 627,647,000.00 627,647,000.00 627,647,000.00 0.00 0.00 0.00 N/A N/A 0.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Profit Loss From Operating Activities 557,588,000.00 669,801,000.00 379,588,000.00 112,213,000.00 -87,993,000.00 -194,633,000.00 -241,617,000.00 -313,547,000.00 -106,640,000.00 -46,984,000.00 -192,100,000.00 -409,730,000.00 -281,764,000.00 -70,785,000.00 -217,630,000.00 127,966,000.00 N/A 915,965,000.00 589,904,000.00 546,210,000.00 -326,061,000.00
Finance Income 16,779,000.00 44,302,000.00 97,922,000.00 34,445,000.00 6,912,000.00 18,625,000.00 30,994,000.00 50,233,000.00 11,713,000.00 12,369,000.00 19,008,000.00 80,965,000.00 90,999,000.00 78,537,000.00 61,957,000.00 10,034,000.00 N/A 66,709,000.00 97,461,000.00 26,363,000.00 38,087,000.00
Finance Costs 58,780,000.00 86,526,000.00 195,534,000.00 34,668,000.00 48,650,000.00 101,856,000.00 146,059,000.00 191,116,000.00 53,206,000.00 44,203,000.00 97,527,000.00 177,711,000.00 296,367,000.00 339,363,000.00 80,184,000.00 118,656,000.00 N/A 63,536,000.00 102,738,000.00 29,915,000.00 46,537,000.00
Profit Loss Before Tax 515,587,000.00 627,577,000.00 281,976,000.00 111,990,000.00 -129,731,000.00 -277,864,000.00 -356,682,000.00 -454,430,000.00 -148,133,000.00 -78,818,000.00 -270,619,000.00 -506,476,000.00 -487,132,000.00 -331,611,000.00 -235,857,000.00 19,344,000.00 N/A 919,138,000.00 584,627,000.00 542,658,000.00 -334,511,000.00
Income Tax Expense Continuing Operations 1,009,000.00 1,724,000.00 4,455,000.00 715,000.00 1,114,000.00 3,239,000.00 5,861,000.00 10,345,000.00 2,125,000.00 2,622,000.00 1,324,000.00 2,637,000.00 9,873,000.00 15,771,000.00 1,313,000.00 7,236,000.00 N/A 4,692,000.00 10,828,000.00 4,579,000.00 6,136,000.00
Profit (loss) 514,578,000.00 625,853,000.00 277,521,000.00 111,275,000.00 -130,845,000.00 -281,103,000.00 -362,543,000.00 -464,775,000.00 -150,258,000.00 -81,440,000.00 -271,943,000.00 -509,113,000.00 -497,005,000.00 -347,382,000.00 -237,170,000.00 12,108,000.00 376,367,000.00 914,446,000.00 573,799,000.00 538,079,000.00 -340,647,000.00
Line item in (dkk) 01.01.2020 01.04.2020 01.07.2020 01.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 02.01.2021 01.04.2022 01.07.2022 01.10.2022 01.01.2023 02.01.2022 01.04.2023 01.07.2023 01.10.2023 02.01.2023
Profit (loss) N/A 514,578,000.00 111,275,000.00 277,521,000.00 -130,845,000.00 -150,258,000.00 -81,440,000.00 -464,775,000.00 N/A -271,943,000.00 -237,170,000.00 12,108,000.00 -347,382,000.00 N/A 376,367,000.00 538,079,000.00 -340,647,000.00 N/A
Adjustments For Income Tax Expense N/A 1,009,000.00 1,724,000.00 4,455,000.00 1,114,000.00 3,239,000.00 5,861,000.00 10,345,000.00 N/A 1,324,000.00 2,637,000.00 9,873,000.00 15,771,000.00 N/A N/A 4,692,000.00 10,828,000.00 N/A
Adjustments For Finance Costs N/A 58,780,000.00 86,526,000.00 195,534,000.00 48,650,000.00 101,856,000.00 146,059,000.00 191,116,000.00 N/A 97,527,000.00 177,711,000.00 296,367,000.00 339,363,000.00 N/A N/A 63,536,000.00 102,738,000.00 N/A
Adjustments For Decrease Increase In Inventories N/A -86,002,000.00 -53,834,000.00 -420,320,000.00 -31,749,000.00 -146,361,000.00 -32,196,000.00 41,039,000.00 N/A -123,527,000.00 -38,366,000.00 -111,171,000.00 -439,029,000.00 N/A N/A -459,811,000.00 -691,356,000.00 N/A
Adjustments For Depreciation And Amortisation Expense N/A N/A N/A N/A 89,256,000.00 186,647,000.00 285,211,000.00 388,310,000.00 N/A 98,403,000.00 197,713,000.00 296,121,000.00 399,247,000.00 N/A N/A 251,618,000.00 961,615,000.00 N/A
Adjustments For Provisions N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A -371,000.00 387,000.00 N/A
Adjustments For Sharebased Payments N/A 6,360,000.00 16,886,000.00 32,998,000.00 26,238,000.00 34,390,000.00 55,381,000.00 56,857,000.00 N/A 6,642,000.00 25,508,000.00 33,429,000.00 49,284,000.00 N/A N/A 31,596,000.00 41,395,000.00 N/A
Cash Flows From Used In Operations N/A 440,822,000.00 685,961,000.00 610,042,000.00 -111,400,000.00 -368,183,000.00 -245,014,000.00 -337,741,000.00 N/A 20,747,000.00 -133,884,000.00 620,000.00 228,957,000.00 N/A N/A 250,771,000.00 547,322,000.00 N/A
Cash Flows From Used In Operating Activities N/A 432,027,000.00 672,281,000.00 571,911,000.00 -119,535,000.00 -377,266,000.00 -247,117,000.00 -358,500,000.00 N/A 23,796,000.00 -119,792,000.00 2,603,000.00 220,053,000.00 N/A N/A 227,786,000.00 533,759,000.00 N/A
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 1,835,449,000.00 1,835,449,000.00 N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 22,787,000.00 66,261,000.00 204,833,000.00 81,177,000.00 171,411,000.00 307,166,000.00 483,127,000.00 N/A 150,018,000.00 242,467,000.00 295,047,000.00 361,244,000.00 N/A N/A 183,391,000.00 213,648,000.00 N/A
Cash Flows From Used In Investing Activities N/A -630,145,000.00 -1,944,953,000.00 -1,911,532,000.00 -1,069,407,000.00 -1,179,496,000.00 -1,355,880,000.00 -2,876,946,000.00 N/A -290,909,000.00 -487,511,000.00 -290,783,000.00 -877,405,000.00 N/A N/A -701,583,000.00 -801,848,000.00 N/A
Proceeds From Issuing Shares N/A N/A N/A N/A N/A N/A N/A 2,856,596,000.00 N/A N/A N/A N/A 0.00 N/A N/A N/A N/A N/A
Payments To Acquire Or Redeem Entitys Shares N/A 0.00 0.00 11,099,000.00 0.00 8,581,000.00 8,581,000.00 8,581,000.00 N/A N/A 9,328,000.00 9,328,000.00 9,328,000.00 N/A N/A 8,988,000.00 8,988,000.00 N/A
Proceeds From Borrowings Classified As Financing Activities N/A N/A 0.00 0.00 N/A 306,706,000.00 456,418,000.00 660,000,000.00 N/A 80,000,000.00 320,000,000.00 400,000,000.00 1,003,661,000.00 N/A N/A 240,000,000.00 240,000,000.00 N/A
Repayments Of Borrowings Classified As Financing Activities N/A 1,382,918,000.00 1,383,457,000.00 1,375,598,000.00 544,000.00 1,088,000.00 1,630,000.00 2,173,000.00 N/A 545,000.00 1,089,000.00 1,617,000.00 374,339,000.00 N/A N/A 1,104,614,000.00 1,105,076,000.00 N/A
Payments Of Lease Liabilities Classified As Financing Activities N/A 3,548,000.00 8,360,000.00 17,799,000.00 4,853,000.00 9,745,000.00 14,608,000.00 19,507,000.00 N/A 4,686,000.00 10,415,000.00 16,115,000.00 21,981,000.00 N/A N/A 12,981,000.00 24,070,000.00 N/A
Cash Flows From Used In Financing Activities N/A 1,363,041,000.00 1,351,992,000.00 1,334,874,000.00 1,146,119,000.00 1,454,979,000.00 1,655,265,000.00 3,536,080,000.00 N/A 75,389,000.00 300,652,000.00 404,966,000.00 635,820,000.00 N/A N/A 734,168,000.00 722,617,000.00 N/A
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 1,164,923,000.00 79,320,000.00 -4,747,000.00 -42,823,000.00 -101,783,000.00 52,268,000.00 300,634,000.00 N/A -191,724,000.00 -306,651,000.00 116,786,000.00 -21,532,000.00 N/A 700,444,000.00 260,371,000.00 454,528,000.00 N/A
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A 2,055,000.00 56,000.00 -7,311,000.00 3,171,000.00 2,197,000.00 4,067,000.00 5,699,000.00 N/A 1,270,000.00 5,632,000.00 10,040,000.00 5,119,000.00 N/A N/A -3,976,000.00 2,247,000.00 N/A
Cash and cash equivalents 297,545,000.00 1,464,523,000.00 376,921,000.00 285,487,000.00 245,835,000.00 185,901,000.00 341,822,000.00 591,820,000.00 285,487,000.00 401,366,000.00 290,801,000.00 718,646,000.00 575,407,000.00 591,820,000.00 1,271,717,000.00 831,802,000.00 1,032,182,000.00 575,407,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
/ ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

DK0015998017

LEI

2138006JCDVYIN6INP51

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Nasdaq Copenhagen

Stock Index

OMX Copenhagen 20

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.